Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
NCT04530383
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Cystic Fibrosis-related Diabetes
Cystic Fibrosis
Interventions
DRUG:
Metformin Hydrochloride
Sponsor
University of Kansas Medical Center